Trexbio Closes The Final Tranche Of $59 Million Series A Financing To Advance Innovation In Tissue Immunobiology For The Treatment Of Cancer And Inflammatory Diseases
Amount Raised
$59 Million
Round Type
Series A
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
TRexBio, a discovery stage company decoding human tissue immune biology to create revolutionary therapeutics, announced the successful close of the final tranche of a $59 million Series A financing. Proceeds from the financing will be used to expand the company’s unique discovery platform that maps human tissue regulatory T cell (Treg) behavior to dysregulation in disease, and to advance its six preclinical therapeutic programs. Investors include Eli Lilly and Company (Lilly), SV Health, Johnson & Johnson Innovation, Pfizer Ventures, and Alexandria Venture Investments.
Quick answer
TRex Bio raised $59 Million in a Series A round, dated June 22, 2021. TRex Bio is based in South San Francisco, California, United States.
- How much did TRex Bio raise?
- TRex Bio raised $59 Million in a Series A round on June 22, 2021.
- What does TRex Bio do?
- TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and..
- Where is TRex Bio based and how big is it?
- TRex Bio is based in South San Francisco, California, United States. Fundz records about 62 employees.
- Who are the decision-makers at TRex Bio?
- Fundz holds 1 contact at TRex Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as TRex Bio that raised within 45 days of this round, from Fundz verified event records.
- Renovacor, Inc. raised $2.5M (Seed) on August 4, 2021.
- Turnstone Biologics Corp raised $80M (Series D) on July 21, 2021.
- Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.
- Century Therapeutics raised $11M on July 19, 2021.
- Turnstone Biologics Corp raised $80M on July 14, 2021.
- Nimbus Therapeutics raised $105M (Funding Round) on July 13, 2021.
Who to call at TRex Bio, and when
A new round usually means TRex Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TRex Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TRex Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TRex Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TRex Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTRex Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.